Monthly Archives: February 2021

Gemini Therapeutics Debut as a Listed Precision Medicine Company Focused on Age-Related Macular Degeneration

CAMBRIDGE, Mass .– (COMMERCIAL THREAD) – Gemini Therapeutics, a clinical-stage precision medicine company that develops innovative treatments for genetically defined age-related macular degeneration (AMD), today announced the completion of its combination with FS Development Corp. (Nasdaq: FSDC), a Specific Purpose Acquisition (SPAC) sponsored by Foresite Capital. Gemini Therapeutics, Inc., the …

Read More »